| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
2e-05 |
| mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-05 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
| mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
2e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
3e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |